We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 06, 2020

Increased Risk of Second Incident Cancer in Patients With CLL Receiving BTK Inhibitors



Additional Info

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors
Leukemia 2020 Jul 23;[EPub Ahead of Print], DA Bond, Y Huang, JL Fisher, AS Ruppert, DH Owen, EM Bertino, KA Rogers, SA Bhat, MR Grever, SM Jaglowski, KJ Maddocks, JC Byrd, JA Woyach

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading